CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-24 | McCarthy Sean A. President and CEO | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2018-01-05 | McCarthy Sean A. President and CEO | Option exercise | +6,526 | $1.13 | $7K | 11,169 |
| 2018-01-05 | McCarthy Sean A. President and CEO | Sale | −6,526 | $25.01 | $163K | 4,643 |
| 2018-01-05 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (right to buy) | −6,526 | 337,143 | ||
| 2018-01-05 | GLUCK FREDERICK W Director | Sale | −10,000 | $25.01 | $250K | 296,643 |
| 2018-01-02 | McCarthy Sean A. President and CEO | Option exercise | +13,052 | $1.13 | $15K | 17,695 |
| 2018-01-02 | McCarthy Sean A. President and CEO | Sale | −13,052 | $21.04 | $275K | 4,643 |
| 2018-01-02 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (right to buy) | −13,052 | 343,669 | ||
| 2018-01-02 | RAY DEBANJAN Chief Financial Officer | Sale | −2,500 | $21.11 | $53K | 7,289 |
| 2017-12-26 | GLUCK FREDERICK W Director | Sale | −5,000 | $22.29 | $111K | 306,643 |
| 2017-12-15 | HUMPHREY RACHEL Chief Medical Officer | Option exercise | +15,117 | $6.61 | $100K | 30,234 |
| 2017-12-15 | HUMPHREY RACHEL Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −15,117 | 262,980 | ||
| 2017-12-08 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | Option exercise | +5,130 | $1.57 | $8K | 19,047 |
| 2017-12-08 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | Option exercise · Stock Option (Right to Buy) | −5,130 | 240,912 | ||
| 2017-12-01 | RAY DEBANJAN Chief Financial Officer | Sale | −2,500 | $20.58 | $51K | 9,789 |
| 2017-12-01 | McCarthy Sean A. President and CEO | Option exercise | +4,100 | $0.95 | $4K | 8,743 |
| 2017-12-01 | McCarthy Sean A. President and CEO | Option exercise | +10,240 | $1.13 | $12K | 18,983 |
| 2017-12-01 | McCarthy Sean A. President and CEO | Sale | −14,340 | $20.60 | $295K | 4,643 |
| 2017-12-01 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (right to buy) | −4,100 | 115,193 | ||
| 2017-12-01 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (right to buy) | −10,240 | 356,721 |
Page 21 of 33 · 649 trades